Abstract
| Lingua originale | English |
|---|---|
| pagine (da-a) | 44-55 |
| Numero di pagine | 12 |
| Rivista | CURRENT IMMUNOLOGY REVIEW |
| Volume | 13 |
| Stato di pubblicazione | Published - 2017 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
Cita questo
HSP60 is a ubiquitous player in the physiological and pathogenic interactions between the chaperoning and the immune systems. / Caruso Bavisotto, Celeste; Campanella, Claudia; Marino Gammazza, Antonella; Rappa, Francesca; Cappello, Francesco; David, Sabrina; Barone, Rosario; Campanella, Claudia; Gammazza, Antonella Marino; Barone, Rosario; Rappa, Francesca; Bavisotto, Celeste Caruso; De Macario, Everly Conway; Cappello, Francesco; Macario, Alberto J. L.
In: CURRENT IMMUNOLOGY REVIEW, Vol. 13, 2017, pag. 44-55.Risultato della ricerca: Article
}
TY - JOUR
T1 - HSP60 is a ubiquitous player in the physiological and pathogenic interactions between the chaperoning and the immune systems
AU - Caruso Bavisotto, Celeste
AU - Campanella, Claudia
AU - Marino Gammazza, Antonella
AU - Rappa, Francesca
AU - Cappello, Francesco
AU - David, Sabrina
AU - Barone, Rosario
AU - Campanella, Claudia
AU - Gammazza, Antonella Marino
AU - Barone, Rosario
AU - Rappa, Francesca
AU - Bavisotto, Celeste Caruso
AU - De Macario, Everly Conway
AU - Cappello, Francesco
AU - Macario, Alberto J. L.
PY - 2017
Y1 - 2017
N2 - HSP60 participates in many interactions between the system integrated by all chaperones and closely associated molecules (chaperoning system or CS) and the immune system (IS). These interactions occur constantly to maintain normal cell physiology but, occasionally, they are perturbed and become mediators of pathologic events that may lead to disease. This switch to pathology may be initiated by various factors, genetic or acquired, which cause qualitative and/or quantitative modifications of HSP60, or immune crossreactivity between the human and microbial chaperonin orthologs, or a break in the balance between the pro- and anti-inflammatory actions of the chaperonin. Thus, autoimmune and chronic inflammatory pathologies may occur. Likewise, a perturbation of the CS-IS interactions, e.g., those that take place during ageing, may favor carcinogenesis. HSP60 may be commandeered by tumor cells to assist its high-rate protein synthesis and, also, to be an emissary among the devices tumor cells utilize to avoid anti-tumor immune reactions. Here, we briefly discuss the canonical and non-canonical functions of HSP/chaperones; and HSP60 as a multifunctional molecule, its migration itinerary, and its possible roles during carcinogenesis and in certain chronic inflammatory and autoimmune diseases. We examine the potential of HSP60 as a biomarker useful for diagnosing and monitoring the progression of the various conditions in which it actively participates. Lastly, we discuss the use HSP60 as target for controlling its activity when it is an etiopathogenic factor, or as a therapeutic agent to correct its deficiency.
AB - HSP60 participates in many interactions between the system integrated by all chaperones and closely associated molecules (chaperoning system or CS) and the immune system (IS). These interactions occur constantly to maintain normal cell physiology but, occasionally, they are perturbed and become mediators of pathologic events that may lead to disease. This switch to pathology may be initiated by various factors, genetic or acquired, which cause qualitative and/or quantitative modifications of HSP60, or immune crossreactivity between the human and microbial chaperonin orthologs, or a break in the balance between the pro- and anti-inflammatory actions of the chaperonin. Thus, autoimmune and chronic inflammatory pathologies may occur. Likewise, a perturbation of the CS-IS interactions, e.g., those that take place during ageing, may favor carcinogenesis. HSP60 may be commandeered by tumor cells to assist its high-rate protein synthesis and, also, to be an emissary among the devices tumor cells utilize to avoid anti-tumor immune reactions. Here, we briefly discuss the canonical and non-canonical functions of HSP/chaperones; and HSP60 as a multifunctional molecule, its migration itinerary, and its possible roles during carcinogenesis and in certain chronic inflammatory and autoimmune diseases. We examine the potential of HSP60 as a biomarker useful for diagnosing and monitoring the progression of the various conditions in which it actively participates. Lastly, we discuss the use HSP60 as target for controlling its activity when it is an etiopathogenic factor, or as a therapeutic agent to correct its deficiency.
KW - Autoimmunity
KW - Cancer
KW - Chaperoning system
KW - Exosomes
KW - HSP60
KW - Immune system
KW - Immunology
KW - Immunology and Allergy
KW - Inflammation
UR - http://hdl.handle.net/10447/353453
UR - http://www.benthamdirect.org/pages/all_b_bypublication.php
M3 - Article
VL - 13
SP - 44
EP - 55
JO - Current Immunology Reviews
JF - Current Immunology Reviews
SN - 1573-3955
ER -